30. Survival at predefined time points in chemotherapy trials, long term follow up studies only*.

	On study mortality data set			Overall survival data set
Time after date of randomization	Deaths	ESA versus control HR (95% CI)**	P value	Deaths	ESA versus control HR (95% CI)*	P value
At 4 months	499	1.14 (95% CI 0.95‐1.36)	0.153	604	1.14 (95% CI 0.97‐1.34)	0.119
At 8 months	658	1.18 (95% CI 1.01‐1.37)	0.040	1346	1.01 (95% CI 0.91‐1.13)	0.842
At 12 months	738	1.20 (95% CI 1.03‐1.39)	0.016	1952	1.03 (95% CI 0.94‐1.13)	0.527
At 24 months	‐	‐	‐	2594	1.05 (95% CI 0.97‐1.14)	0.191
At 36 months	‐	‐	‐	2789	1.04 (95% CI 0.97‐1.12)	0.290
At 60 months	‐	‐	‐	2878	1.05 (95% CI 0.98‐1.13)	0.182

*6509 patients from the chemotherapy treatment population stemming from trials that were designed for long term follow up were under observation. 
 ** Based on Cox fixed‐effects model stratified by study